Healthcare Business Intelligence Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global healthcare business intelligence market size is expected to touch USD 23.6 Billion by 2030, from USD 9.43 Billion in 2022, growing with a significant CAGR of 12.15% from 2022 to 2030.

The healthcare business intelligence report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global healthcare business intelligence in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global healthcare business intelligence market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global healthcare business intelligence during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1653

 Report Scope of the Healthcare Business Intelligence Market

Report Coverage	Details
Market Size by 2030	USD 23.6 Billion
Growth Rate from 2022 to 2030	CAGR of 12.15%
Software Segment Market Share in 2021	70%
North America Makret Share in 2021	47.5%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Component, Mode of Delivery, Application, End Use, Function, Geography

This study covers a detailed segmentation of the global healthcare business intelligence market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global healthcare business intelligence market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• IBM Corporation
• Microsoft
• Oracle
• SAP SE
• SAS Institute Inc.
• Tableau Software
• QlikTech International AB
• MicroStrategy Incorporated
• Information Builders
• BOARD International

Market Segmentation

 By Component

• Software
• Services

By Mode of Delivery

• On-premise
• Cloud-based
• Hybrid

By Application

• Financial Analysis
• Claims Processing
• Revenue Cycle Management
• Payment Integrity and Fraud, Waste, & Abuse (FWA)
• Risk Adjustment and Risk Assessment
• Clinical Analysis
• Quality Improvement and Clinical Benchmarking
• Clinical Decision Support
• Regulatory Reporting and Compliance
• Comparative Analytics/Effectiveness
• Precision Health
• Operational Analysis
• Supply Chain Analysis
• Workforce Analysis
• Strategic Analysis
• Patient Care

By End Use

• Payers
• Healthcare Providers
• Healthcare Manufacturers

By Function

• Query and Reporting
• OLAP and Visualization
• Performance Management

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global healthcare business intelligence report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global healthcare business intelligence market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Business Intelligence Market 

5.1. COVID-19 Landscape: Healthcare Business Intelligence Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Business Intelligence Market, By End Use Type

8.1. Healthcare Business Intelligence Market, by End Use Type, 2022-2030

8.1.1. Payers

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Healthcare Providers

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Healthcare Manufacturers

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare Business Intelligence Market, By Mode of Delivery Type

9.1. Healthcare Business Intelligence Market, by Mode of Delivery Type, 2022-2030

9.1.1. On-premise

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Cloud-based

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Hybrid

Chapter 10. Global Healthcare Business Intelligence Market, By Application Type 

10.1. Healthcare Business Intelligence Market, by Application Type, 2022-2030

10.1.1. Financial Analysis

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Clinical Analysis

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Operational Analysis

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Patient Care

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Healthcare Business Intelligence Market, By Function Type

11.1. Healthcare Business Intelligence Market, by Function Type, 2022-2030

11.1.1. Query and Reporting

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. OLAP and Visualization

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Performance Management

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Healthcare Business Intelligence Market, By Component Type

12.1. Healthcare Business Intelligence Market, by Component, 2022-2030

12.1.1. Software

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Services

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Healthcare Business Intelligence  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by End Use (2017-2030)

13.1.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.1.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.4. Market Revenue and Forecast, by Function (2017-2030)

13.1.5. Market Revenue and Forecast, by Component (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by End Use (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Function (2017-2030)

13.1.7. Market Revenue and Forecast, by Component (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by End Use (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Function (2017-2030)

13.1.8.5. Market Revenue and Forecast, by Component (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by End Use (2017-2030)

13.2.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.2.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.4. Market Revenue and Forecast, by Function (2017-2030) 

13.2.5. Market Revenue and Forecast, by Component (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by End Use (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.7. Market Revenue and Forecast, by Function (2017-2030) 

13.2.8. Market Revenue and Forecast, by Component (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by End Use (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.10. Market Revenue and Forecast, by Function (2017-2030)

13.2.11. Market Revenue and Forecast, by Component (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by End Use (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Function (2017-2030)

13.2.13. Market Revenue and Forecast, by Component (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by End Use (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Function (2017-2030)

13.2.15. Market Revenue and Forecast, by Component (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by End Use (2017-2030)

13.3.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.3.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.4. Market Revenue and Forecast, by Function (2017-2030)

13.3.5. Market Revenue and Forecast, by Component (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by End Use (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Function (2017-2030)

13.3.7. Market Revenue and Forecast, by Component (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by End Use (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Function (2017-2030)

13.3.9. Market Revenue and Forecast, by Component (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by End Use (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Function (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Component (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by End Use (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Function (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Component (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by End Use (2017-2030)

13.4.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.4.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.4. Market Revenue and Forecast, by Function (2017-2030)

13.4.5. Market Revenue and Forecast, by Component (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by End Use (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Function (2017-2030)

13.4.7. Market Revenue and Forecast, by Component (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by End Use (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Function (2017-2030)

13.4.9. Market Revenue and Forecast, by Component (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by End Use (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Function (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Component (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by End Use (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Function (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Component (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by End Use (2017-2030)

13.5.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.5.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.4. Market Revenue and Forecast, by Function (2017-2030)

13.5.5. Market Revenue and Forecast, by Component (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by End Use (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Function (2017-2030)

13.5.7. Market Revenue and Forecast, by Component (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by End Use (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Mode of Delivery (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Function (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Component (2017-2030)

Chapter 14. Company Profiles

14.1. IBM Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Microsoft

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Oracle

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. SAP SE

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. SAS Institute Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Tableau Software

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. QlikTech International AB

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. MicroStrategy Incorporated

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Information Builders

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. BOARD International

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com